13 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
requiring establishment and maintenance of effective disclosure and financial controls, changes in corporate governance practices, proxy access and “say
10-K
cn20pu7vohb02n2oay6
25 Mar 14
Annual report
12:00am
10-Q
rwomec9iq77wfhxy
13 Nov 13
Quarterly report
12:00am
424B4
swi9c
25 Sep 13
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next